SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 32.31+1.4%Nov 26 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: aknahow who wrote (7635)11/3/1998 5:49:00 PM
From: Bluegreen  Read Replies (2) of 17367
 
Which brings me to the thought that time is short in hearing from the DSMB. Funny George how some are engrossed in sepsis debate when they know quantity of of gram neg. bacteria providing LPS is key in my opinion. Now how about bacteria replicating even though assaulted by conventional antibiotics? What if you had a natural product which helps conventional antibiotics?<g> Then would trigger to sepsis be as likely? Some researchers in denial of endotoxin effects apparently don't know of the LPS-LBP-CD14 connection. But I guess when you see Lutsar and the gang dumping BPI in spinal fluid expecting a cure for meningitis, anything's possible!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext